{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29204251", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "09"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "24"}], "Language": ["eng"], "ELocationID": ["8214541", "10.1155/2017/8214541"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2017", "PubDate": {"Year": "2017"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective.", "Pagination": {"StartPage": "8214541", "MedlinePgn": "8214541"}, "Abstract": {"AbstractText": ["Diabetic cardiomyopathy is one of the major complications among patients with diabetes mellitus. Diabetic cardiomyopathy (DCM) is featured by left ventricular hypertrophy, myocardial fibrosis, and damaged left ventricular systolic and diastolic functions. The pathophysiological mechanisms include metabolic-altered substrate metabolism, dysfunction of microvascular, renin-angiotensin-aldosterone system (RAAS) activation, oxidative stress, cardiomyocyte apoptosis, mitochondrial dysfunction, and impaired Ca<sup>2+</sup> handling. An array of molecules and signaling pathways such as p38 mitogen-activated protein kinase (p38 MAPK), c-Jun N-terminal kinase (JNK), and extracellular-regulated protein kinases (ERK) take roles in the pathogenesis of DCM. Currently, there was no remarkable effect in the treatment of DCM with application of single Western medicine. The myocardial protection actions of herbs have been gearing much attention. We present a review of the progress research of herbal medicine as a potential therapy for diabetic cardiomyopathy and the underlying mechanisms."]}, "AuthorList": [{"Identifier": ["0000-0002-3610-6814"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China."}, {"Identifier": [], "Affiliation": "Cardiovascular Disease Centre, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China."}], "LastName": "Tian", "ForeName": "Jinfan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Disease Centre, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China."}, {"Identifier": [], "Affiliation": "School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong."}], "LastName": "Zhao", "ForeName": "Yingke", "Initials": "Y"}, {"Identifier": ["0000-0001-7706-6495"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China."}], "LastName": "Liu", "ForeName": "Yanfei", "Initials": "Y"}, {"Identifier": ["0000-0002-0084-863X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Disease Centre, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China."}], "LastName": "Liu", "ForeName": "Yue", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Disease Centre, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China."}], "LastName": "Chen", "ForeName": "Keji", "Initials": "K"}, {"Identifier": ["0000-0003-4843-2761"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China."}], "LastName": "Lyu", "ForeName": "Shuzheng", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "Mitogen-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Diabetic Cardiomyopathies"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mitogen-Activated Protein Kinases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Renin-Angiotensin System"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Falc\u00e3o-Pires I., Leite-Moreira A. F. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Failure Reviews. 2012;17(3):325\u2013344. doi: 10.1007/s10741-011-9257-z.", "ArticleIdList": ["10.1007/s10741-011-9257-z", "21626163"]}, {"Citation": "Miki T., Yuda S., Kouzu H., Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Failure Reviews. 2013;18(2):149\u2013166. doi: 10.1007/s10741-012-9313-3.", "ArticleIdList": ["10.1007/s10741-012-9313-3", "PMC3593009", "22453289"]}, {"Citation": "Li J., Casteels T., Frogne T., et al. Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity. Cell. 2017;168(1-2):86\u2013100.e15. doi: 10.1016/j.cell.2016.11.010.", "ArticleIdList": ["10.1016/j.cell.2016.11.010", "PMC5236063", "27916275"]}, {"Citation": "Cosson S., Kevorkian J. P. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes & Metabolism. 2003;29(5):455\u2013466. doi: 10.1016/s1262-3636(07)70059-9.", "ArticleIdList": ["10.1016/s1262-3636(07)70059-9", "14631322"]}, {"Citation": "Amaral N., Okonko D. O. Metabolic abnormalities of the heart in type II diabetes. Diabetes and Vascular Disease Research. 2015;12(4):239\u2013248. doi: 10.1177/1479164115580936.", "ArticleIdList": ["10.1177/1479164115580936", "25941161"]}, {"Citation": "Taegtmeyer H., McNulty P., Young M. E. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation. 2002;105(14):1727\u20131733. doi: 10.1161/01.cir.0000012466.50373.e8.", "ArticleIdList": ["10.1161/01.cir.0000012466.50373.e8", "11940554"]}, {"Citation": "Young M. E., McNulty P., Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation. 2002;105(15):1861\u20131870. doi: 10.1161/01.cir.0000012467.61045.87.", "ArticleIdList": ["10.1161/01.cir.0000012467.61045.87", "11956132"]}, {"Citation": "Zeng S. Y., Chen X., Chen S. R., et al. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression. Canadian Journal of Cardiology. 2013;29(10):1310\u20131319. doi: 10.1016/j.cjca.2013.04.026.", "ArticleIdList": ["10.1016/j.cjca.2013.04.026", "23850346"]}, {"Citation": "Sirker A., Zhang M., Murdoch C., Shah A. M. Involvement of NADPH oxidases in cardiac remodelling and heart failure. American Journal of Nephrology. 2007;27(6):649\u2013660. doi: 10.1159/000109148.", "ArticleIdList": ["10.1159/000109148", "17901689"]}, {"Citation": "Duncan J. G. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2011;1813(7):1351\u20131359. doi: 10.1016/j.bbamcr.2011.01.014.", "ArticleIdList": ["10.1016/j.bbamcr.2011.01.014", "PMC3149859", "21256163"]}, {"Citation": "Lebeche D., Davidoff A. J., Hajjar R. J. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nature Clinical Practice Cardiovascular Medicine. 2008;5(11):715\u2013724. doi: 10.1038/ncpcardio1347.", "ArticleIdList": ["10.1038/ncpcardio1347", "18813212"]}, {"Citation": "Zhao X. Y., Hu S. J., Li J., Mou Y., Chen B. P., Xia Q. Decreased cardiac sarcoplasmic reticulum Ca2+ \u2212ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats. Journal of Physiology and Biochemistry. 2006;62(1):1\u20138. doi: 10.1007/bf03165800.", "ArticleIdList": ["10.1007/bf03165800", "16909926"]}, {"Citation": "Jiang X., Liu W., Deng J., et al. Polydatin protects cardiac function against burn injury by inhibiting sarcoplasmic reticulum Ca2+ leak by reducing oxidative modification of ryanodine receptors. Free Radical Biology & Medicine. 2013;60:292\u2013299. doi: 10.1016/j.freeradbiomed.2013.02.030.", "ArticleIdList": ["10.1016/j.freeradbiomed.2013.02.030", "23499836"]}, {"Citation": "Yan D., Luo X., Li Y., et al. Effects of advanced glycation end products on calcium handling in cardiomyocytes. Cardiology. 2014;129(2):75\u201383. doi: 10.1159/000364779.", "ArticleIdList": ["10.1159/000364779", "25138529"]}, {"Citation": "Buja L. M., Vela D. Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovascular Pathology. 2008;17(6):349\u2013374. doi: 10.1016/j.carpath.2008.02.004.", "ArticleIdList": ["10.1016/j.carpath.2008.02.004", "18402842"]}, {"Citation": "Xie Z., He C., Zou M. H. AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy. Autophagy. 2011;7(10):1254\u20131255. doi: 10.4161/auto.7.10.16740.", "ArticleIdList": ["10.4161/auto.7.10.16740", "PMC3210311", "21685727"]}, {"Citation": "Xie Z., Lau K., Eby B., et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes. 2011;60(6):1770\u20131778. doi: 10.2337/db10-0351.", "ArticleIdList": ["10.2337/db10-0351", "PMC3114402", "21562078"]}, {"Citation": "Zhao Y., Zhang L., Qiao Y., et al. Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS One. 2013;8(9, article e75927) doi: 10.1371/journal.pone.0075927.", "ArticleIdList": ["10.1371/journal.pone.0075927", "PMC3782439", "24086665"]}, {"Citation": "Hou X., Hu Z., Xu H., et al. Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway. Cardiovascular Diabetology. 2014;13(1):p. 78. doi: 10.1186/1475-2840-13-78.", "ArticleIdList": ["10.1186/1475-2840-13-78", "PMC3998738", "24725502"]}, {"Citation": "Palomer X., Salvad\u00f3 L., Barroso E., V\u00e1zquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. International Journal of Cardiology. 2013;168(4):3160\u20133172. doi: 10.1016/j.ijcard.2013.07.150.", "ArticleIdList": ["10.1016/j.ijcard.2013.07.150", "23932046"]}, {"Citation": "Wang S., Ding L., Ji H., Xu Z., Liu Q., Zheng Y. The role of p38 MAPK in the development of diabetic cardiomyopathy. International Journal of Molecular Sciences. 2016;17(7) doi: 10.3390/ijms17071037.", "ArticleIdList": ["10.3390/ijms17071037", "PMC4964413", "27376265"]}, {"Citation": "Min W., Bin Z. W., Quan Z. B., Hui Z. J., Sheng F. G. The signal transduction pathway of PKC/NF-\u03baB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats. Cardiovascular Diabetology. 2009;8(1):p. 8. doi: 10.1186/1475-2840-8-8.", "ArticleIdList": ["10.1186/1475-2840-8-8", "PMC2652442", "19210763"]}, {"Citation": "Van Linthout S., Riad A., Dhayat N., et al. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia. 2007;50(9):1977\u20131986. doi: 10.1007/s00125-007-0719-8.", "ArticleIdList": ["10.1007/s00125-007-0719-8", "17589825"]}, {"Citation": "Ko S. Y., Lin I. H., Shieh T. M., et al. Cell hypertrophy and MEK/ERK phosphorylation are regulated by glyceraldehyde-derived AGEs in cardiomyocyte H9c2 cells. Cell Biochemistry and Biophysics. 2013;66(3):537\u2013544. doi: 10.1007/s12013-012-9501-8.", "ArticleIdList": ["10.1007/s12013-012-9501-8", "23288619"]}, {"Citation": "Tanaka K., Honda M., Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. Journal of the American College of Cardiology. 2001;37(2):676\u2013685. doi: 10.1016/s0735-1097(00)01123-2.", "ArticleIdList": ["10.1016/s0735-1097(00)01123-2", "11216996"]}, {"Citation": "Tang M., Zhang W., Lin H., Jiang H., Dai H., Zhang Y. High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2. Molecular and Cellular Biochemistry. 2007;301(1-2):109\u2013114. doi: 10.1007/s11010-006-9401-6.", "ArticleIdList": ["10.1007/s11010-006-9401-6", "17206378"]}, {"Citation": "Zhang C., Huang Z., Gu J., et al. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway. Diabetologia. 2015;58(8):1937\u20131948. doi: 10.1007/s00125-015-3630-8.", "ArticleIdList": ["10.1007/s00125-015-3630-8", "26040473"]}, {"Citation": "Xu Z., Sun J., Tong Q., et al. The role of ERK1/2 in the development of diabetic cardiomyopathy. International Journal of Molecular Sciences. 2016;17(12) doi: 10.3390/ijms17122001.", "ArticleIdList": ["10.3390/ijms17122001", "PMC5187801", "27941647"]}, {"Citation": "Tsai K. H., Wang W. J., Lin C. W., et al. NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK-dependent activation of NF-\u03baB in cardiomyocytes exposed to high glucose. Journal of Cellular Physiology. 2012;227(4):1347\u20131357. doi: 10.1002/jcp.22847.", "ArticleIdList": ["10.1002/jcp.22847", "21604272"]}, {"Citation": "Jeon S. M. Regulation and function of AMPK in physiology and diseases. Experimental & Molecular Medicine. 2016;48(7, article e245) doi: 10.1038/emm.2016.81.", "ArticleIdList": ["10.1038/emm.2016.81", "PMC4973318", "27416781"]}, {"Citation": "Cabarcas S. M., Hurt E. M., Farrar W. L. Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease. Current Molecular Medicine. 2010;10(8):744\u2013755. doi: 10.2174/156652410793384187.", "ArticleIdList": ["10.2174/156652410793384187", "PMC3448443", "20937021"]}, {"Citation": "Woods A., Johnstone S. R., Dickerson K., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Current Biology. 2003;13(22):2004\u20132008. doi: 10.1016/j.cub.2003.10.031.", "ArticleIdList": ["10.1016/j.cub.2003.10.031", "14614828"]}, {"Citation": "Woods A., Dickerson K., Heath R., et al. Ca2+/calmodulin-dependent protein kinase kinase-\u03b2 acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism. 2005;2(1):21\u201333. doi: 10.1016/j.cmet.2005.06.005.", "ArticleIdList": ["10.1016/j.cmet.2005.06.005", "16054096"]}, {"Citation": "Holmes B. F., Sparling D. P., Olson A. L., Winder W. W., Dohm G. L. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. American Journal of Physiology - Endocrinology and Metabolism. 2005;289(6):E1071\u2013E1076. doi: 10.1152/ajpendo.00606.2004.", "ArticleIdList": ["10.1152/ajpendo.00606.2004", "16105857"]}, {"Citation": "Habets D. D., Coumans W. A., El Hasnaoui M., et al. Crucial role for LKB1 to AMPK\u03b12 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2009;1791(3):212\u2013219. doi: 10.1016/j.bbalip.2008.12.009.", "ArticleIdList": ["10.1016/j.bbalip.2008.12.009", "19159696"]}, {"Citation": "Garton A. J., Campbell D. G., Carling D., Hardie D. G., Colbran R. J., Yeaman S. J. Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. European Journal of Biochemistry. 1989;179(1):249\u2013254. doi: 10.1111/j.1432-1033.1989.tb14548.x.", "ArticleIdList": ["10.1111/j.1432-1033.1989.tb14548.x", "2537200"]}, {"Citation": "Salminen A., Ojala J., Huuskonen J., Kauppinen A., Suuronen T., Kaarniranta K. Interaction of aging-associated signaling cascades: Inhibition of NF-\u03baB signaling by longevity factors FoxOs and SIRT1. Cellular and Molecular Life Sciences. 2008;65(7-8):1049\u20131058. doi: 10.1007/s00018-008-7461-3.", "ArticleIdList": ["10.1007/s00018-008-7461-3", "18193389"]}, {"Citation": "Salminen A., Hyttinen J. M., Kaarniranta K. AMP-activated protein kinase inhibits NF-\u03baB signaling and inflammation: impact on healthspan and lifespan. Journal of Molecular Medicine. 2011;89(7):667\u2013676. doi: 10.1007/s00109-011-0748-0.", "ArticleIdList": ["10.1007/s00109-011-0748-0", "PMC3111671", "21431325"]}, {"Citation": "Egan D., Kim J., Shaw R. J., Guan K. L. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy. 2011;7(6):643\u2013644. doi: 10.4161/auto.7.6.15123.", "ArticleIdList": ["10.4161/auto.7.6.15123", "PMC3359466", "21460621"]}, {"Citation": "Shaw R. J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiologica. 2009;196(1):65\u201380. doi: 10.1111/j.1748-1716.2009.01972.x.", "ArticleIdList": ["10.1111/j.1748-1716.2009.01972.x", "PMC2760308", "19245654"]}, {"Citation": "He C., Zhu H., Li H., Zou M. H., Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes. 2013;62(4):1270\u20131281. doi: 10.2337/db12-0533.", "ArticleIdList": ["10.2337/db12-0533", "PMC3609561", "23223177"]}, {"Citation": "Zou M. H., Xie Z. Regulation of interplay between autophagy and apoptosis in the diabetic heart: new role of AMPK. Autophagy. 2013;9(4):624\u2013625. doi: 10.4161/auto.23577.", "ArticleIdList": ["10.4161/auto.23577", "PMC3627682", "23380689"]}, {"Citation": "Finck B. N., Lehman J. J., Leone T. C., et al. The cardiac phenotype induced by PPAR\u03b1 overexpression mimics that caused by diabetes mellitus. Journal of Clinical Investigation. 2002;109(1):121\u2013130. doi: 10.1172/JCI14080.", "ArticleIdList": ["10.1172/JCI14080", "PMC150824", "11781357"]}, {"Citation": "Burkart E. M., Sambandam N., Han X., et al. Nuclear receptors PPAR\u03b2/\u03b4 and PPAR\u03b1 direct distinct metabolic regulatory programs in the mouse heart. Journal of Clinical Investigation. 2007;117(12):3930\u20133939. doi: 10.1172/JCI32578.", "ArticleIdList": ["10.1172/JCI32578", "PMC2082147", "18037994"]}, {"Citation": "Botta A., Laher I., Beam J., et al. Short term exercise induces PGC-1\u03b1, ameliorates inflammation and increases mitochondrial membrane proteins but fails to increase respiratory enzymes in aging diabetic hearts. PLoS One. 2013;8(8, article e70248) doi: 10.1371/journal.pone.0070248.", "ArticleIdList": ["10.1371/journal.pone.0070248", "PMC3731348", "23936397"]}, {"Citation": "Wang H., Bei Y., Lu Y., et al. Exercise prevents cardiac injury and improves mitochondrial biogenesis in advanced diabetic cardiomyopathy with PGC-1a and Akt activation. Cellular Physiology and Biochemistry. 2015;35(6):2159\u20132168. doi: 10.1159/000374021.", "ArticleIdList": ["10.1159/000374021", "25896313"]}, {"Citation": "Buroker N. E., Barboza J., Huang J. Y. The I\u03baB\u03b1 gene is a peroxisome proliferator-activated receptor cardiac target gene. FEBS Journal. 2009;276(12):3247\u20133255. doi: 10.1111/j.1742-4658.2009.07039.x.", "ArticleIdList": ["10.1111/j.1742-4658.2009.07039.x", "19438714"]}, {"Citation": "Planavila A., Rodr\u00edguez-Calvo R., Jov\u00e9 M., et al. Peroxisome proliferator-activated receptor \u03b2/\u03b4 activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovascular Research. 2005;65(4):832\u2013841. doi: 10.1016/j.cardiores.2004.11.011.", "ArticleIdList": ["10.1016/j.cardiores.2004.11.011", "15721863"]}, {"Citation": "Asakawa M., Takano H., Nagai T., et al. Peroxisome proliferator-activated receptor \u03b3 plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation. 2002;105(10):1240\u20131246. doi: 10.1161/hc1002.105225.", "ArticleIdList": ["10.1161/hc1002.105225", "11889020"]}, {"Citation": "Lan F., Cacicedo J. M., Ruderman N., Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. Journal of Biological Chemistry. 2008;283(41):27628\u201327635. doi: 10.1074/jbc.M805711200.", "ArticleIdList": ["10.1074/jbc.M805711200", "PMC2562073", "18687677"]}, {"Citation": "Pan W., Yu H., Huang S., Zhu P. Resveratrol protects against TNF-\u03b1-induced injury in human umbilical endothelial cells through promoting sirtuin-1-induced repression of NF-KB and p38 MAPK. PLoS One. 2016;11(1, article e0147034) doi: 10.1371/journal.pone.0147034.", "ArticleIdList": ["10.1371/journal.pone.0147034", "PMC4723256", "26799794"]}, {"Citation": "Sulaiman M., Matta M. J., Sunderesan N. R., Gupta M. P., Periasamy M., Gupta M. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. American Journal of Physiology - Heart and Circulatory Physiology. 2010;298(3):H833\u2013H843. doi: 10.1152/ajpheart.00418.2009.", "ArticleIdList": ["10.1152/ajpheart.00418.2009", "PMC2838561", "20008278"]}, {"Citation": "Karbasforooshan H., Karimi G. The role of SIRT1 in diabetic cardiomyopathy. Biomedicine & Pharmacotherapy. 2017;90:386\u2013392. doi: 10.1016/j.biopha.2017.03.056.", "ArticleIdList": ["10.1016/j.biopha.2017.03.056", "28380414"]}, {"Citation": "He X., Kan H., Cai L., Ma Q. Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. Journal of Molecular and Cellular Cardiology. 2009;46(1):47\u201358. doi: 10.1016/j.yjmcc.2008.10.007.", "ArticleIdList": ["10.1016/j.yjmcc.2008.10.007", "19007787"]}, {"Citation": "Yu M., Liu Y., Zhang B., Shi Y., Cui L., Zhao X. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Cardiovascular Pathology. 2015;24(6):375\u2013381. doi: 10.1016/j.carpath.2015.06.003.", "ArticleIdList": ["10.1016/j.carpath.2015.06.003", "26164195"]}, {"Citation": "Jeyabal P., Thandavarayan R. A., Joladarashi D., et al. MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochemical and Biophysical Research Communications. 2016;471(4):423\u2013429. doi: 10.1016/j.bbrc.2016.02.065.", "ArticleIdList": ["10.1016/j.bbrc.2016.02.065", "PMC4818978", "26898797"]}, {"Citation": "Zheng D., Ma J., Yu Y., et al. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice. Diabetologia. 2015;58(8):1949\u20131958. doi: 10.1007/s00125-015-3622-8.", "ArticleIdList": ["10.1007/s00125-015-3622-8", "PMC4499474", "25994075"]}, {"Citation": "Liu S., Li W., Xu M., Huang H., Wang J., Chen X. Micro-RNA 21 targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts. Canadian Journal of Cardiology. 2014;30(12):1689\u20131699. doi: 10.1016/j.cjca.2014.07.747.", "ArticleIdList": ["10.1016/j.cjca.2014.07.747", "25418215"]}, {"Citation": "Singh G. B., Raut S. K., Khanna S., et al. MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy. Molecular and Cellular Biochemistry. 2017;424(1-2):1\u201311. doi: 10.1007/s11010-016-2838-3.", "ArticleIdList": ["10.1007/s11010-016-2838-3", "27696308"]}, {"Citation": "Raut S. K., Kumar A., Singh G. B., et al. miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy. Cardiovascular Therapeutics. 2015;33(3):89\u201397. doi: 10.1111/1755-5922.12113.", "ArticleIdList": ["10.1111/1755-5922.12113", "25781190"]}, {"Citation": "Li X., Du N., Zhang Q., et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death and Disease. 2014;5, article e1479 doi: 10.1038/cddis.2014.430.", "ArticleIdList": ["10.1038/cddis.2014.430", "PMC4237254", "25341033"]}, {"Citation": "Qiu D., Kao P. N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs in R&D. 2003;4(1):1\u201318. doi: 10.2165/00126839-200304010-00001.", "ArticleIdList": ["10.2165/00126839-200304010-00001", "12568630"]}, {"Citation": "Li R., Lu K., Wang Y., et al. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression. Biochemical and Biophysical Research Communications. 2017;485(1):69\u201375. doi: 10.1016/j.bbrc.2017.02.021.", "ArticleIdList": ["10.1016/j.bbrc.2017.02.021", "28202417"]}, {"Citation": "Wen H. L., Liang Z. S., Zhang R., Yang K. Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovascular Diabetology. 2013;12(1):p. 50. doi: 10.1186/1475-2840-12-50.", "ArticleIdList": ["10.1186/1475-2840-12-50", "PMC3617021", "23530831"]}, {"Citation": "Liang Z., Leo S., Wen H., Ouyang M., Jiang W., Yang K. Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats. BMC Cardiovascular Disorders. 2015;15:p. 42. doi: 10.1186/s12872-015-0030-4.", "ArticleIdList": ["10.1186/s12872-015-0030-4", "PMC4431461", "25967112"]}, {"Citation": "Guo X., Xue M., Li C. J., et al. Protective effects of triptolide on TLR4 mediated autoimmune and inflammatory response induced myocardial fibrosis in diabetic cardiomyopathy. Journal of Ethnopharmacology. 2016;193:333\u2013344. doi: 10.1016/j.jep.2016.08.029.", "ArticleIdList": ["10.1016/j.jep.2016.08.029", "27558948"]}, {"Citation": "Soetikno V., Watanabe K., Sari F. R., et al. Curcumin attenuates diabetic nephropathy by inhibiting PKC-\u03b1 and PKC-\u03b21 activity in streptozotocin-induced type I diabetic rats. Molecular Nutrition & Food Research. 2011;55(11):1655\u20131665. doi: 10.1002/mnfr.201100080.", "ArticleIdList": ["10.1002/mnfr.201100080", "22045654"]}, {"Citation": "Soetikno V., Sari F. R., Sukumaran V., et al. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. European Journal of Pharmaceutical Sciences. 2012;47(3):604\u2013614. doi: 10.1016/j.ejps.2012.04.018.", "ArticleIdList": ["10.1016/j.ejps.2012.04.018", "22564708"]}, {"Citation": "Pan Y., Wang Y., Zhao Y., et al. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes. 2014;63(10):3497\u20133511. doi: 10.2337/db13-1577.", "ArticleIdList": ["10.2337/db13-1577", "24848068"]}, {"Citation": "Wang Y., Zhou S., Sun W., et al. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression. American Journal of Physiology - Endocrinology and Metabolism. 2014;306(11):E1239\u2013E1247. doi: 10.1152/ajpendo.00629.2013.", "ArticleIdList": ["10.1152/ajpendo.00629.2013", "24714399"]}, {"Citation": "Fitzl G., Martin R., Dettmer D., Hermsdorf V., Drews H., Welt K. Protective effects of Gingko biloba extract EGb 761 on myocardium of experimentally diabetic rats. I: ultrastructural and biochemical investigation on cardiomyocytes. Experimental and Toxicologic Pathology. 1999;51(3):189\u2013198. doi: 10.1016/S0940-2993(99)80093-1.", "ArticleIdList": ["10.1016/S0940-2993(99)80093-1", "10334457"]}, {"Citation": "Welt K., Weiss J., Koch S., Fitzl G. Protective effects of Ginkgo biloba extract EGb 761 on the myocardium of experimentally diabetic rats. II. Ultrastructural and immunohistochemical investigation on microvessels and interstitium. Experimental and Toxicologic Pathology. 1999;51(3):213\u2013222. doi: 10.1016/S0940-2993(99)80099-2.", "ArticleIdList": ["10.1016/S0940-2993(99)80099-2", "10334461"]}, {"Citation": "Fitzl G., Welt K., Martin R., et al. The influence of hypoxia on the myocardium of experimentally diabetic rats with and without protection by Ginkgo biloba extract. I. Ultrastructural and biochemical investigations on cardiomyocytes. Experimental and Toxicologic Pathology. 2000;52(5):419\u2013430. doi: 10.1016/S0940-2993(00)80075-5.", "ArticleIdList": ["10.1016/S0940-2993(00)80075-5", "11089893"]}, {"Citation": "Welt K., Fitzl G., Schepper A. Experimental hypoxia of STZ-diabetic rat myocardium and protective effects of Ginkgo biloba extract. II. Ultrastructural investigation of microvascular endothelium. Experimental and Toxicologic Pathology. 2001;52(6):503\u2013512. doi: 10.1016/S0940-2993(01)80006-3.", "ArticleIdList": ["10.1016/S0940-2993(01)80006-3", "11256752"]}, {"Citation": "Saini A. S., Taliyan R., Sharma P. L. Protective effect and mechanism of Ginkgo biloba extract-EGb 761 on STZ-induced diabetic cardiomyopathy in rats. Pharmacognosy Magazine. 2014;10(38):172\u2013178. doi: 10.4103/0973-1296.131031.", "ArticleIdList": ["10.4103/0973-1296.131031", "PMC4048565", "24914284"]}, {"Citation": "Su H. C., Hung L. M., Chen J. K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. American Journal of Physiology - Endocrinology and Metabolism. 2006;290(6):E1339\u2013E1346. doi: 10.1152/ajpendo.00487.2005.", "ArticleIdList": ["10.1152/ajpendo.00487.2005", "16434553"]}, {"Citation": "Turan B., Tuncay E., Vassort G. Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. Journal of Bioenergetics and Biomembranes. 2012;44(2):281\u2013296. doi: 10.1007/s10863-012-9429-0.", "ArticleIdList": ["10.1007/s10863-012-9429-0", "22437738"]}, {"Citation": "Penumathsa S. V., Thirunavukkarasu M., Zhan L., et al. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. Journal of Cellular and Molecular Medicine. 2008;12(6A):2350\u20132361. doi: 10.1111/j.1582-4934.2008.00251.x.", "ArticleIdList": ["10.1111/j.1582-4934.2008.00251.x", "PMC4514113", "18266981"]}, {"Citation": "Guo S., Yao Q., Ke Z., Chen H., Wu J., Liu C. Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Molecular and Cellular Endocrinology. 2015;412:85\u201394. doi: 10.1016/j.mce.2015.05.034.", "ArticleIdList": ["10.1016/j.mce.2015.05.034", "26054749"]}, {"Citation": "Yar A. S., Menevse S., Alp E. The effects of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats. Genetics and Molecular Research. 2011;10(4):2962\u20132975. doi: 10.4238/2011.November.29.7.", "ArticleIdList": ["10.4238/2011.November.29.7", "22179968"]}, {"Citation": "Chen W., Li Y. M., Yu M. H. Effects of astragalus polysaccharides on chymase, angiotensin-converting enzyme and angiotensin II in diabetic cardiomyopathy in hamsters. Journal of International Medical Research. 2007;35(6):873\u2013877. doi: 10.1177/147323000703500615.", "ArticleIdList": ["10.1177/147323000703500615", "18035000"]}, {"Citation": "Chen W., Yu M. H., Li Y. M., Chen W. J., Xia Y. P. Beneficial effects of astragalus polysaccharides treatment on cardiac chymase activities and cardiomyopathy in diabetic hamsters. Acta Diabetologica. 2010;47(Supplement 1):35\u201346. doi: 10.1007/s00592-009-0116-5.", "ArticleIdList": ["10.1007/s00592-009-0116-5", "19350199"]}, {"Citation": "Chen W., Li Y. M., Yu M. H. Astragalus polysaccharides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation. Journal of Diabetes and its Complications. 2010;24(3):199\u2013208. doi: 10.1016/j.jdiacomp.2008.12.003.", "ArticleIdList": ["10.1016/j.jdiacomp.2008.12.003", "19230716"]}, {"Citation": "Chen W., Xia Y. P., Chen W. J., Yu M. H., Li Y. M., Ye H. Y. Improvement of myocardial glycolipid metabolic disorder in diabetic hamster with astragalus polysaccharides treatment. Molecular Biology Reports. 2012;39(7):7609\u20137615. doi: 10.1007/s11033-012-1595-y.", "ArticleIdList": ["10.1007/s11033-012-1595-y", "22426864"]}, {"Citation": "Sun S., Yang S., Dai M., et al. The effect of astragalus polysaccharides on attenuation of diabetic cardiomyopathy through inhibiting the extrinsic and intrinsic apoptotic pathways in high glucose -stimulated H9C2 cells. BMC Complementary and Alternative Medicine. 2017;17(1):p. 310. doi: 10.1186/s12906-017-1828-7.", "ArticleIdList": ["10.1186/s12906-017-1828-7", "PMC5470251", "28610566"]}, {"Citation": "Yu J., Fei J., Azad J., Gong M., Lan Y., Chen G. Myocardial protection by Salvia miltiorrhiza injection in streptozotocin-induced diabetic rats through attenuation of expression of thrombospondin-1 and transforming growth factor-\u03b21. Journal of International Medical Research. 2012;40(3):1016\u20131024. doi: 10.1177/147323001204000320.", "ArticleIdList": ["10.1177/147323001204000320", "22906274"]}, {"Citation": "Lo S. H., Hsu C. T., Niu H. S., Niu C. S., Cheng J. T., Chen Z. C. Cryptotanshinone inhibits STAT3 signaling to alleviate cardiac fibrosis in type 1-like diabetic rats. Phytotherapy Research. 2017;31(4):638\u2013646. doi: 10.1002/ptr.5777.", "ArticleIdList": ["10.1002/ptr.5777", "28176375"]}, {"Citation": "Rani N., Bharti S., Bhatia J., Nag T. C., Ray R., Arya D. S. Chrysin, a PPAR-\u03b3 agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation. Chemico-Biological Interactions. 2016;250:59\u201367. doi: 10.1016/j.cbi.2016.03.015.", "ArticleIdList": ["10.1016/j.cbi.2016.03.015", "26972669"]}, {"Citation": "Rani N., Bharti S., Bhatia J., et al. Inhibition of TGF-\u03b2 by a novel PPAR-\u03b3 agonist, chrysin, salvages \u03b2-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism. Nutrition & Metabolism. 2015;12:p. 11. doi: 10.1186/s12986-015-0004-7.", "ArticleIdList": ["10.1186/s12986-015-0004-7", "PMC4359541", "25774203"]}, {"Citation": "Zhang B., Shen Q., Chen Y., et al. Myricitrin alleviates oxidative stress-induced inflammation and apoptosis and protects mice against diabetic cardiomyopathy. Scientific Reports. 2017;7, article 44239 doi: 10.1038/srep44239.", "ArticleIdList": ["10.1038/srep44239", "PMC5347164", "28287141"]}, {"Citation": "Mahajan U. B., Chandrayan G., Patil C. R., et al. The protective effect of apigenin on myocardial injury in diabetic rats mediating activation of the PPAR-\u03b3 pathway. International Journal of Molecular Sciences. 2017;18(4) doi: 10.3390/ijms18040756.", "ArticleIdList": ["10.3390/ijms18040756", "PMC5412341", "28375162"]}, {"Citation": "Sun X., Chen R. C., Yang Z. H., et al. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis. Food and Chemical Toxicology. 2014;63:221\u2013232. doi: 10.1016/j.fct.2013.11.013.", "ArticleIdList": ["10.1016/j.fct.2013.11.013", "24269735"]}, {"Citation": "Yu Y., Zheng G. Troxerutin protects against diabetic cardiomyopathy through NF-\u03baB/AKT/IRS1 in a rat model of type 2 diabetes. Molecular Medicine Reports. 2017;15(6):3473\u20133478. doi: 10.3892/mmr.2017.6456.", "ArticleIdList": ["10.3892/mmr.2017.6456", "PMC5436284", "28440404"]}, {"Citation": "Agrawal Y. O., Sharma P. K., Shrivastava B., Arya D. S., Goyal S. N. Hesperidin blunts streptozotocin-isoproternol induced myocardial toxicity in rats by altering of PPAR-\u03b3 receptor. Chemico-Biological Interactions. 2014;219:211\u2013220. doi: 10.1016/j.cbi.2014.06.010.", "ArticleIdList": ["10.1016/j.cbi.2014.06.010", "24954035"]}, {"Citation": "Zhang N., Yang Z., Xiang S. Z., et al. Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy. Molecular and Cellular Biochemistry. 2016;417(1-2):87\u201396. doi: 10.1007/s11010-016-2716-z.", "ArticleIdList": ["10.1007/s11010-016-2716-z", "27160937"]}, {"Citation": "Chen J., Guo R., Yan H., et al. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells. Basic & Clinical Pharmacology & Toxicology. 2014;114(4):293\u2013304. doi: 10.1111/bcpt.12153.", "ArticleIdList": ["10.1111/bcpt.12153", "24118820"]}, {"Citation": "Zhang Y., Zhang L., Zhang Y., Xu J. J., Sun L. L., Li S. Z. The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-\u03baB and MAPK signaling pathway. Biomedicine & Pharmacotherapy. 2016;84:1337\u20131349. doi: 10.1016/j.biopha.2016.10.036.", "ArticleIdList": ["10.1016/j.biopha.2016.10.036", "27810791"]}, {"Citation": "Xie X. W. Liquiritigenin attenuates cardiac injury induced by high fructose-feeding through fibrosis and inflammation suppression. Biomedicine & Pharmacotherapy. 2017;86:694\u2013704. doi: 10.1016/j.biopha.2016.12.066.", "ArticleIdList": ["10.1016/j.biopha.2016.12.066", "28039849"]}, {"Citation": "Zhao J., Cao T. T., Tian J., et al. Shengmai san ameliorates myocardial dysfunction and fibrosis in diabetic db/db mice. Evidence-Based Complementary and Alternative Medicine. 2016;2016:9. doi: 10.1155/2016/4621235.4621235", "ArticleIdList": ["10.1155/2016/4621235", "PMC4856913", "27200101"]}, {"Citation": "Ni Q., Wang J., Li E. Q., et al. Study on the protective effect of the mixture of Shengmai powder and Danshen decoction on the myocardium of diabetic cardiomyopathy in the rat model. Chinese Journal of Integrative Medicine. 2011;17(2):116\u2013125. doi: 10.1007/s11655-011-0639-9.", "ArticleIdList": ["10.1007/s11655-011-0639-9", "21390578"]}, {"Citation": "Sen S., Chen S., Wu Y., Feng B., Lui E. K., Chakrabarti S. Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy. Phytotherapy Research. 2013;27(2):290\u2013298. doi: 10.1002/ptr.4719.", "ArticleIdList": ["10.1002/ptr.4719", "22566158"]}, {"Citation": "Gu J. N., Niu J., Pi Z. F., Yue H., Wu S. S., Liu S. Y. Study on the mechanism of total saponins of panax ginseng in treatment of diabetic cardiomyopathy in rat assessed by urine metabonomics. Chinese Journal of Analytical Chemistry. 2013;41(3):371\u2013376. [Article in Chinese]"}, {"Citation": "Yu H. T., Zhen J., Pang B., Gu J. N., Wu S. S. Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats. Journal of Zhejiang University-Science B. 2015;16(5):344\u2013354. doi: 10.1631/jzus.B1400204.", "ArticleIdList": ["10.1631/jzus.B1400204", "PMC4432986", "25990051"]}, {"Citation": "Xu Z., Wang S., Ji H., et al. Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice. Science Reports. 2016;6, article 30252 doi: 10.1038/srep30252.", "ArticleIdList": ["10.1038/srep30252", "PMC4960533", "27457280"]}, {"Citation": "Zhang Z., Zhang D., Dou M., Li Z., Zhang J., Zhao X. Dendrobium officinale Kimura et Migo attenuates diabetic cardiomyopathy through inhibiting oxidative stress, inflammation and fibrosis in streptozotocin-induced mice. Biomedicine & Pharmacotherapy. 2016;84:1350\u20131358. doi: 10.1016/j.biopha.2016.10.074.", "ArticleIdList": ["10.1016/j.biopha.2016.10.074", "27802903"]}, {"Citation": "Yu W., Zha W., Guo S., Cheng H., Wu J., Liu C. Flos Puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice. PLoS One. 2014;9(5, article e98044) doi: 10.1371/journal.pone.0098044.", "ArticleIdList": ["10.1371/journal.pone.0098044", "PMC4035321", "24865768"]}, {"Citation": "Hou J., Zheng D., Fung G., et al. Mangiferin suppressed advanced glycation end products (AGEs) through NF-\u03baB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats. Canadian Journal of Physiology and Pharmacology. 2016;94(3):332\u2013340. doi: 10.1139/cjpp-2015-0073.", "ArticleIdList": ["10.1139/cjpp-2015-0073", "26751764"]}, {"Citation": "Xi S., Zhou G., Zhang X., Zhang W., Cai L., Zhao C. Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms. Experimental and Molecular Medicine. 2009;41(8):538\u2013547. doi: 10.3858/emm.2009.41.8.059.", "ArticleIdList": ["10.3858/emm.2009.41.8.059", "PMC2739893", "19381071"]}, {"Citation": "Duan J., Wei G., Guo C., et al. Aralia taibaiensis protects cardiac myocytes against high glucose-induced oxidative stress and apoptosis. The American Journal of Chinese Medicine. 2015;43(6):1159\u20131175. doi: 10.1142/S0192415X15500664.", "ArticleIdList": ["10.1142/S0192415X15500664", "26446201"]}, {"Citation": "Chang W., Zhang M., Li J., et al. Berberine improves insulin resistance in cardiomyocytes via activation of 5\u2032-adenosine monophosphate-activated protein kinase. Metabolism. 2013;62(8):1159\u20131167. doi: 10.1016/j.metabol.2013.02.007.", "ArticleIdList": ["10.1016/j.metabol.2013.02.007", "23537779"]}, {"Citation": "Chang W., Zhang M., Meng Z., et al. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5\u2032-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. European Journal of Pharmacology. 2015;769:55\u201363. doi: 10.1016/j.ejphar.2015.10.043.", "ArticleIdList": ["10.1016/j.ejphar.2015.10.043", "26522928"]}, {"Citation": "Shen N., Li X., Zhou T., et al. Shensong Yangxin capsule prevents diabetic myocardial fibrosis by inhibiting TGF-\u03b21/Smad signaling. Journal of Ethnopharmacology. 2014;157:161\u2013170. doi: 10.1016/j.jep.2014.09.035.", "ArticleIdList": ["10.1016/j.jep.2014.09.035", "25267579"]}]}], "History": [{"Year": "2017", "Month": "7", "Day": "13"}, {"Year": "2017", "Month": "9", "Day": "4"}, {"Year": "2017", "Month": "9", "Day": "13"}, {"Year": "2017", "Month": "12", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29204251", "PMC5674516", "10.1155/2017/8214541"]}}]}